# Axis B: Neuro-Immunology & Glia Heterogeneity
*Focus: Microglia states, neuroinflammation, and peripheral-central immune crosstalk.*

## 1. ç¥ç¶“å…ç–«äº¤äº’ä½œç”¨åœ?(Neuro-Immune Interaction)

```text
   [ Peripheral Blood ]             ||             [ CNS / Brain ]
                                    ||
   ( T-cells / Myeloid ) â”€â”€â”€ğŸšªâ”€â”€â–¶ï¸  ||  â”€â”€â”€ğŸ’¥â”€â”€â–?[ DAM Microglia ]
          Patrol                    ||             (Activated)
                                    ||                 â”?
   [ Gut Microbiome ]               ||                 â–?
          â”?                        ||         [ Neuroinflammation ]
          â””â”€â”€â”€(SCFAs)â”€â”€â–?[ Metabolic Gate ]            â”?
                                    ||                 â–?
                                    ||         [ â˜ ï¸ Neuronal Loss ]
                                    ||
                             ( BLOOD-BRAIN BARRIER )
```

## 2. æ ¸å¿ƒé‚è¼¯ (Core Logic)
è…¦é€€åŒ–ç—…ä¸å†è¢«è¦–ç‚ºå–®ç´”çš„ã€Œç¥ç¶“å…ƒç–¾ç—…ã€ï¼Œè€Œè¢«ç†è§£ç‚ºä¸€ç¨?*æ…¢æ€§ç¥ç¶“ç‚ç—?(Chronic Neuroinflammation)**ã€‚ç›®å‰çš„ç§‘ç ”ç¯„å¼æ­£å¾ã€Œæ¶ˆé™¤ç‚ç—‡ã€è½‰å‘ã€Œèª¿ç¯€å…ç–«ç‹€æ…?(Modulating States)ã€ã€?

## 3. é—œéµç ”ç©¶ç·šç´¢ (Key Clues)

### A. å¾®è† è³ªç´°èƒ?(Microglia) çš„é›™å‘æ€?
- **å‚³çµ±èªçŸ¥**ï¼šMicroglia åªæœ‰ M1 (ä¿ƒç‚) å’?M2 (æŠ‘ç‚) å…©ç¨®ç‹€æ…‹ã€?
- **2024-2025 ç™¼ç¾**ï¼šå–®ç´°èƒå®šåº (scRNA-seq) æ­ç¤ºäº?**DAM (Disease-Associated Microglia)** çš„ç´°åˆ†ç‹€æ…‹ã€‚éƒ¨åˆ?DAM åœ¨æ—©æœŸå…¶å¯¦å…·æœ‰ä¿è­·æ€§ï¼ˆè² è²¬åå™¬ AÎ²ï¼‰ï¼Œä½†åœ¨æ™šæœŸå‰‡è½‰è®Šç‚ºç¥ç¶“æ¯’æ€§ã€?
- **ç·šç´¢ (Clue)**ï¼šæ²»ç™‚æ™‚æ©Ÿæ˜¯é—œéµã€‚åœ¨æ—©æœŸæ´»åŒ– DAM å¯èƒ½æœ‰ç›Šï¼Œä½†åœ¨ä¸­æ™šæœŸå‰‡éœ€æŠ‘åˆ¶å…¶ä¿ƒç‚è·¯å¾‘ã€?

### B. T ç´°èƒåœ¨å¤§è…¦ä¸­çš„ã€Œéæ³•å…¥å¢ƒã€èˆ‡ä½œç”¨
- **2025 ç™¼ç¾ (Science)**ï¼šç ”ç©¶è­‰æ˜åœ¨ AD æ‚£è€…å¤§è…¦çš„ã€Œç¥ç¶“å…ç–«ç”Ÿæ…‹ä½ (Neuro-immune Niche)ã€ä¸­å­˜åœ¨å¤§é‡å¤–å‘¨ T ç´°èƒã€?
- **é‚è¼¯è½‰å‘**ï¼šå¤§è…¦ä¸¦éå®Œå…¨çš„ã€Œå…ç–«ç‰¹æ¬Šå€ (Immune Privileged)ã€ã€‚å¤–å‘¨å…ç–«ç´°èƒçš„æ»²é€æ˜¯é€€åŒ–åŠ é€Ÿçš„é—œéµå› å­ã€?

## 4. æŠ€è¡“çªç ´é» (Technical Edge)
- **Spatial Transcriptomics (ç©ºé–“è½‰éŒ„çµ?**ï¼šè®“æˆ‘å€‘çœ‹æ¸…å…ç–«ç´°èƒæ˜¯åœ¨ã€Œå“ªè£¡ã€èˆ‡ç¥ç¶“å…ƒç™¼ç”Ÿæˆ°é¬¥ï¼Œè€Œéåƒ…åƒ…çŸ¥é“å®ƒå€‘å­˜åœ¨ã€?

## 5. å¾…é©—è­‰å‡è¨?(Actionable Hypotheses)
- **å‡è¨­ 1**ï¼šé€šéèª¿ç¯€è…¸é“èŒç¾¤ç”¢ç”Ÿçš„ä»£è¬ç‰©ï¼Œæ˜¯å¦èƒ½é–“æ¥æ”¹è®Š Microglia çš„è¡¨å‹ï¼Ÿ
- **å‡è¨­ 2**ï¼šé˜»æ–·ç‰¹å®šè¶¨åŒ–å› å­?(Chemokines) é˜»æ­¢ T ç´°èƒé€²å…¥å¤§è…¦ï¼Œèƒ½å¦å»¶ç·©èªçŸ¥ä¸‹é™ï¼Ÿ

## 6. åƒè€ƒæ–‡ç?(References)
- **TroulÃ©, K., et al. (2024).** CellPhoneDB v5: inferring cell-cell communication from single-cell multiomics data. *Nature Methods*.
- **Gate, D., et al. (2020/2024 updated).** Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer's disease. *Nature*.
- **Zhen, X., et al. (2024).** GSDMD activation is the key molecular mechanism of inflammatory blood-brain barrier disruption. *Nature*.

---
[å›åˆ°ç›®éŒ„](../README.md)


